INVESTOR NEWS

Nov 15, 2017

Third Quarter Financial Report

Moss, 15 November 2017

Nov 06, 2017

GENTIAN DIAGNOSTICS AS RECEIVES PATENT PROTECTION FOR THE COMPANY'S TECHNOLOGY FOR MONITORING TREATMENT OF HIV INFECTIONS

Moss, 06.11.2017

Oct 03, 2017

A new article published in CC&R is demonstrating the clinical value of plasma Calprotectin as an early biomarker of bacterial infections

Recently, the Critical Care and Resuscitation (CC&R) Journal published an article demonstrating the advantage..